Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.4 USD | -0.55% | -0.74% | +12.09% |
Mar. 14 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
Mar. 13 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.09% | 374M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.42% | 16.72B | |
-25.92% | 15.09B | |
-9.27% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |
- Stock
- Equities
- Stock Anika Therapeutics, Inc. - Nasdaq
- News Anika Therapeutics, Inc.
- Anika Therapeutics Says FDA Approves X-Twist System for Soft Tissue Repair